OptimizeRX (OPRX) PT Lowered to $12 at Stifel, Buy Rating Maintained
Tweet Send to a Friend
(Updated - August 13, 2026 10:21 AM EDT)
Stifel analyst David Grossman lowered the price target on OptimizeRX (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst David Grossman lowered the price target on OptimizeRX (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
